[Treatment of partial epilepsies with a sultiamum containing combination].
D000293:Adolescent; D000328:Adult; D000374:Aggression / Q000187:drug effects; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001463:Barbiturates / Q000009:adverse effects / Q000627:therapeutic use*; D002110:Caffeine / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D005059:Euphoria; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007175:Impulsive Behavior / Q000187:drug effects; D008297:Male; D010292:Paresthesia / Q000139:chemically induced; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use*; D013843:Thiazines / Q000009:adverse effects / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced
D000927:Anticonvulsants; D001463:Barbiturates; D013843:Thiazines; D002110:Caffeine; D010672:Phenytoin
Die Behandlung der partiellen Epilepsien mit einer Sultiamum enthaltenden Kombination.